Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00432822
Status:
TERMINATED
Last Update Posted:
2007-09-20
First Post:
2007-02-07
Brief Title:
Long-Term Tetrahydrobiopterin Treatment in PKU Patients of 0-18 Years - Study on Phenylalanine Tolerance and Safety
Sponsor:
Orphanetics Pharma Entwicklungs GmbH
Organization:
Orphanetics Pharma Entwicklungs GmbH
Organization Data
Organization:
Orphanetics Pharma Entwicklungs GmbH
Class:
INDUSTRY
Study ID:
BH4III05001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Orphanetics Pharma Entwicklungs GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None